On the one hand, a 2020 pilot study showed that increased growth hormone circulation could preserve quadriceps strength in patients whod undergone reconstructive surgery after an anterior cruciate ligament injury;18 on the other, an in vitro study from 2024 found that growth hormone administered to tendon and ligament cells [did] not appear to positively affect cellular proliferation and differentiation.19 More research is needed before we can say for sure whether CJC-1295, ipamorelin, and similar peptide treatments have dependable utility toward injury recovery
Ciccaglione AF, Tavani R, Grossi L, Cellini L, Manzoli L, Marzio L (2016) Rifabutin containing triple therapy and rifabutin with bismuth containing quadruple therapy for third-line treatment of Helicobacter pylori infection: two pilot studies
Perhaps most interesting, injectable GHK-Cu administered in one body area (such as thigh muscles) improved healing at distant locations (such as ears), demonstrating true systemic regenerative enhancement
Timeline and Expectations Understanding realistic timelines helps set appropriate expectations and prevents premature discontinuation before therapeutic effects fully develop
Maintenance dosing after achieving goal weight often allows reduction to 1.8-2.0mg weekly for both peptides, providing 20-30% cost savings while sustaining results
